![origenis_logo_Pantone [Konvertiert]_2020](https://static.wixstatic.com/media/9afeac_83ea95f8f63144538d48a310b96d7f33~mv2.png/v1/fill/w_260,h_53,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/origenis_logo_Pantone%20%5BKonvertiert%5D_2020.png){kind=logo}
May 16, 2019
Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.
Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB
Comments